We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHN
1076
DELISTED
Athenahealth, Inc.
ATHN
$5.29M 0.01%
40,063
-1,177
-3% -$151K
IRDM icon
1077
Iridium Communications
IRDM
$5.26B
$5.26M 0.01%
285,026
+53,879
+23% +$1.11M
OKTA icon
1078
Okta
OKTA
$25.7B
$5.26M 0.01%
82,390
-6,765
-8% -$401K
CRS icon
1079
Carpenter Technology
CRS
$28.3B
$5.25M 0.01%
147,547
+55,827
+61% +$2.52M
CTB
1080
DELISTED
Cooper Tire & Rubber Co.
CTB
$5.25M 0.01%
162,494
+26,776
+20% +$813K
LPLA icon
1081
LPL Financial
LPLA
$27.9B
$5.24M 0.01%
85,861
-5,519
-6% -$336K
NFX
1082
DELISTED
Newfield Exploration
NFX
$5.23M 0.01%
356,590
+2,017
+0.6% +$40.6K
BDC icon
1083
Belden
BDC
$4.98B
$5.19M 0.01%
124,327
+45,008
+57% +$2.45M
KYNB
1084
Kyntra Bio
KYNB
$28M
$5.17M 0.01%
4,468
+1,592
+55% +$1.79M
TREE icon
1085
LendingTree
TREE
$474M
$5.16M 0.01%
23,513
+9,104
+63% +$2.07M
MSGS icon
1086
Madison Square Garden
MSGS
$9.51B
$5.16M 0.01%
27,019
+427
+2% +$83.1K
TTD icon
1087
Trade Desk
TTD
$9.09B
$5.14M 0.01%
442,990
+150,380
+51% +$1.88M
MDRX
1088
DELISTED
Veradigm Inc. Common Stock
MDRX
$5.13M 0.01%
532,258
+193,246
+57% +$2.16M
ESE icon
1089
ESCO Technologies
ESE
$8.45B
$5.12M 0.01%
77,679
+12,514
+19% +$813K
BANR icon
1090
Banner Corp
BANR
$2.44B
$5.11M 0.01%
95,632
+15,418
+19% +$895K
PBH icon
1091
Prestige Consumer Healthcare
PBH
$2.46B
$5.09M 0.01%
164,818
+56,282
+52% +$2.05M
POWI icon
1092
Power Integrations
POWI
$3.6B
$5.08M 0.01%
166,576
+28,286
+20% +$835K
BYD icon
1093
Boyd Gaming
BYD
$6.27B
$5.08M 0.01%
244,347
+84,856
+53% +$2.23M
W icon
1094
Wayfair
W
$15.3B
$5.06M 0.01%
56,169
-1,891
-3% -$199K
SHO icon
1095
Sunstone Hotel Investors
SHO
$2.16B
$5.06M 0.01%
388,592
+100,654
+35% +$1.48M
CIT
1096
DELISTED
CIT Group Inc.
CIT
$5.04M 0.01%
131,730
-11,457
-8% -$520K
SANM icon
1097
Sanmina
SANM
$11.1B
$5.03M 0.01%
208,908
+34,801
+20% +$876K
SIG icon
1098
Signet Jewelers
SIG
$3.78B
$5.02M 0.01%
158,009
+55,576
+54% +$2.79M
NWBI icon
1099
Northwest Bancshares
NWBI
$2.34B
$5.01M 0.01%
295,914
+50,174
+20% +$847K
DY icon
1100
Dycom Industries
DY
$12.5B
$5M 0.01%
92,604
+31,609
+52% +$2.12M

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.